Suppr超能文献

不借助HPV检测解决非典型鳞状细胞意义不明确(ASCUS)的问题:使用手工液基细胞学(MLBC)对剩余的自动化液基细胞学(ALBC)材料进行手工再处理。

Resolving ASCUS without recourse to HPV testing: manual reprocessing of residual automated liquid-based cytology (ALBC) material using manual liquid-based cytology (MLBC).

作者信息

Maksem John A, Bedrossian Carlos W M, Kurtycz Daniel, Sewall Sarah, Shalkham John, Dhanwada Vijaya, Lind Heidi, Bibbo Marluce, Weidmann James, Kane Bruce, Shi Fu Yao

机构信息

Bostwick Laboratories, Orlando, Florida 32809, USA. jmaksem@bostwicklaboratories..com

出版信息

Diagn Cytopathol. 2005 Dec;33(6):434-40. doi: 10.1002/dc.20324.

Abstract

We show that residual cell material from ThinPrep PapTest (Cytyc Corporation, Boxborough, MA) atypical squamous-cells of undetermined significance (ASCUS) cases may be manually reprocessed to triage women into actionable diagnostic categories (HSIL, LSIL, and Negative). Material remaining from each of 358 ThinPrep ASCUS cases was manually reprocessed as two slides, labeled "A" and "B." Interobserver agreement between case contributors (CCs) and three sequential reviewers (SRs) was analyzed with 186 cases (Study 1), and diagnostic reproducibility between SRs was examined with an additional 172 cases (Study 2). In Study 1, CCs classified 33% of cases as LSIL or greater, SRs classified 60% as LSIL or greater, and there was 58% diagnostic agreement between CCs and SRs. No "Negative" case assignment by one group afforded an "HSIL" assignment by the complementary group. In Study 2, there was 95% agreement between SRs A slide and B slide diagnoses with 54% of A slides and 55% of B slides classified as LISL or greater. Again, no "Negative" case assignment to one slide afforded an "HSIL" assignment to the complementary slide. Overall, 12.6% of the 358 cases showed HSIL, and all HSILs by one observer group were ASCUS or greater by the complementary observer group. Using manual reprocessing beyond the 21-day specimen outdate for HPV testing by the Hybrid Capture II High Risk HPV test (HR-HCII; Digene Corporation, Beltsville, MD), many ThinPrep ASCUS cases were reclassified as LSIL or HSIL. The 12.6% HSIL proportion of this study approximated the 11.5% CIN 2 or greater proportion of the ALTS ASCUS arm. Similar to ALTS, manual liquid-based cytology (MLBC) would have referred nearly 60% of women to colposcopy for a definitive diagnosis of HSIL or LSIL without resorting to HPV testing. These data demonstrate that many cases of automated liquid-based cytology (ALBC)-diagnosed ASCUS represent unrecognized SIL, which is present in the ALBC specimen vial at the time the ASCUS diagnosis is rendered.

摘要

我们发现,来自ThinPrep巴氏试验(Cytyc公司,马萨诸塞州博克斯伯勒)意义不明确的非典型鳞状细胞(ASCUS)病例的残余细胞材料可经人工再处理,以便将女性分类到可采取行动的诊断类别(高级别鳞状上皮内病变、低级别鳞状上皮内病变和阴性)中。对358例ThinPrep ASCUS病例的剩余材料进行人工再处理制成两张玻片,分别标记为“A”和“B”。对186例病例(研究1)分析了病例提供者(CCs)与三名连续审阅者(SRs)之间的观察者间一致性,并对另外172例病例(研究2)检验了SRs之间的诊断可重复性。在研究1中,CCs将33%的病例分类为低级别鳞状上皮内病变或更高级别病变,SRs将60%分类为低级别鳞状上皮内病变或更高级别病变,CCs与SRs之间的诊断一致性为58%。一组的“阴性”病例诊断未导致互补组作出“高级别鳞状上皮内病变”的诊断。在研究2中,SRs对A玻片和B玻片诊断的一致性为95%,54%的A玻片和55%的B玻片被分类为低级别鳞状上皮内病变或更高级别病变。同样,一张玻片的“阴性”病例诊断未导致互补玻片作出“高级别鳞状上皮内病变”的诊断。总体而言,358例病例中有12.6%显示为高级别鳞状上皮内病变,一个观察者组诊断的所有高级别鳞状上皮内病变病例在互补观察者组中均为ASCUS或更高级别病变。使用Hybrid Capture II高危型人乳头瘤病毒检测(HR-HCII;Digene公司,马里兰州贝尔茨维尔)对超过21天标本过期时间的HPV检测进行人工再处理后,许多ThinPrep ASCUS病例被重新分类为低级别鳞状上皮内病变或高级别鳞状上皮内病变。本研究中12.6%的高级别鳞状上皮内病变比例接近ALTS ASCUS组中11.5%的2级或更高级别宫颈上皮内瘤变比例。与ALTS类似,人工液基细胞学检查(MLBC)可将近60%的女性转诊至阴道镜检查,以明确诊断高级别鳞状上皮内病变或低级别鳞状上皮内病变,而无需进行HPV检测。这些数据表明,许多自动液基细胞学检查(ALBC)诊断的ASCUS病例代表未被识别的鳞状上皮内病变,在作出ASCUS诊断时,这些病变存在于ALBC标本瓶中。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验